The goals are: (1) to explore and define the relationship of the cardiovirus genus to other members of the picornavirus family, and (2) to exploit unique features of the cardioviruses to examine fundamental questions about picornaviral translation, proteolytic processing and morphogenesis.
One specific aim i s to complete the identification of all enzymes involved in sequential proteolytic processing of the encephalomyocarditis (EMC) polyprotein. Cell-free synthesis, genetic engineering and site-specific mutagenesis techniques will be used to characterize viral protease 3C, a """"""""second"""""""" viral protease (peptide 2A or 2B), and the maturation processing of capsid precursor peptide VPO. Enzyme specificities and cleavage site requirements will also be determined. The 5'on-coding region of EMC will be examined with the aim of characterizing the sequences and possible secondary structures which are necessary for efficient translation of polyprotein in cell-free systems. If possible, a full-length, infectious clone of EMC will be derived, and used to help define the biological role of the cardioviral poly C tract, and other 5' non-coding features.
A third aim i s derivation of the complete nucleotide sequences of two important cardiovirus strains: (1) mengovirus and (2) the diabetogenic varient of EMC, designated EMC-D. The EMC-D virus produces a pronounced diabetes-like syndrome in mice by infecting and destroying pancreatic beta cells. It has been exceptionally well characterized in vivo, and may serve as an animal virus model for insulin-dependent diabetes in man.
A fourth aim i s to compare and contrast available picornaviral sequence data (including those of the cardioviruses) by computer analysis to determine how and where the different viruses are analogous. The information will clarify interviral relationships in terms of genome organization, base compositions, codon frequencies, sequence-predicted antigenic differences, capsid structure (amino acid sequences vs. published crystallographic data) and possible phlogeny.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI017331-10
Application #
3127158
Study Section
Experimental Virology Study Section (EVR)
Project Start
1980-12-01
Project End
1991-11-30
Budget Start
1989-12-01
Budget End
1990-11-30
Support Year
10
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
Other Domestic Higher Education
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Ciomperlik, Jessica J; Basta, Holly A; Palmenberg, Ann C (2016) Cardiovirus Leader proteins bind exportins: Implications for virus replication and nucleocytoplasmic trafficking inhibition. Virology 487:19-26
Ciomperlik, Jessica J; Basta, Holly A; Palmenberg, Ann C (2015) Three cardiovirus Leader proteins equivalently inhibit four different nucleocytoplasmic trafficking pathways. Virology 484:194-202
Bacot-Davis, Valjean R; Ciomperlik, Jessica J; Basta, Holly A et al. (2014) Solution structures of Mengovirus Leader protein, its phosphorylated derivatives, and in complex with nuclear transport regulatory protein, RanGTPase. Proc Natl Acad Sci U S A 111:15792-7
Basta, Holly A; Ashraf, Shamaila; Sgro, Jean-Yves et al. (2014) Modeling of the human rhinovirus C capsid suggests possible causes for antiviral drug resistance. Virology 448:82-90
Basta, Holly A; Palmenberg, Ann C (2014) AMP-activated protein kinase phosphorylates EMCV, TMEV and SafV leader proteins at different sites. Virology 462-463:236-40
Basta, Holly A; Sgro, Jean-Yves; Palmenberg, Ann C (2014) Modeling of the human rhinovirus C capsid suggests a novel topography with insights on receptor preference and immunogenicity. Virology 448:176-84
Petty, Ryan V; Basta, Holly A; Bacot-Davis, Valjean R et al. (2014) Binding interactions between the encephalomyocarditis virus leader and protein 2A. J Virol 88:13503-9
Basta, Holly A; Bacot-Davis, Valjean R; Ciomperlik, Jessica J et al. (2014) Encephalomyocarditis virus leader is phosphorylated by CK2 and syk as a requirement for subsequent phosphorylation of cellular nucleoporins. J Virol 88:2219-26
Bacot-Davis, Valjean R; Palmenberg, Ann C (2013) Encephalomyocarditis virus Leader protein hinge domain is responsible for interactions with Ran GTPase. Virology 443:177-85
Petty, Ryan V; Palmenberg, Ann C (2013) Guanine-nucleotide exchange factor RCC1 facilitates a tight binding between the encephalomyocarditis virus leader and cellular Ran GTPase. J Virol 87:6517-20

Showing the most recent 10 out of 17 publications